Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
Journal of Community Health
|
May 25, 2010
Teen peer educators and diabetes knowledge of low-income fifth grade students
Karen J Coleman, Andrea Yoder Clark, Maggie Shordon, et al.
Drug Discovery Today
|
February 15, 2023
Role of innovation in pharmaceutical regulation: A proposal for principles to evaluate EU General Pharmaceutical Legislation from the innovator perspective
Inkatuuli Heikkinen, Sini Eskola, Virginia Acha, et al.
Population Health Management
|
January 17, 2020
Care Team Integration in Primary Care Improves One-Year Clinical and Financial Outcomes in Diabetes: A Case for Value-Based Care
Addie L Fortmann, Chris Walker, Kelly Barger, et al.
International Journal of Cancer
|
March 7, 2020
Phase 1 study of epacadostat in combination with atezolizumab for patients with previously treated advanced nonsmall cell lung cancer
Matthew D Hellmann, Scott Gettinger, Laura Q M Chow, et al.
Targeted Oncology
|
February 14, 2023
First-in-Human Study of INCB062079, a Fibroblast Growth Factor Receptor 4 Inhibitor, in Patients with Advanced Solid Tumors
James J Harding, Christiane Jungels, Jean-Pascal Machiels, et al.
Applied Optics
|
August 22, 2008
The Hertz/VPM polarimeter: design and first light observations
Megan Krejny, David Chuss, Christian Drouet d'Aubigny, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
March 2, 2022
Cardiorenal risk of celecoxib compared with naproxen or ibuprofen in arthritis patients: insights from the PRECISION trial
Slayman Obeid, Peter Libby, Elaine Husni, et al.
The American Journal of Gastroenterology
|
March 15, 2018
Acute pancreatitis with long-term celecoxib vs. ibuprofen or naproxen: data from the PRECISION trial
Neville D Yeomans, David Y Graham, Qiuqing Wang, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 8, 2023
Phase 1/2 Study of the Pan-PIM Kinase Inhibitor INCB053914 Alone or in Combination With Standard-of-Care Agents in Patients With Advanced Hematologic Malignancies
Manish R Patel, William Donnellan, Michael Byrne, et al.
Cancer
|
October 30, 2022
Phase 1/2 study of epacadostat in combination with durvalumab in patients with metastatic solid tumors
Aung Naing, Alain P Algazi, Gerald S Falchook, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
Journal of Community Health
|
May 25, 2010
Teen peer educators and diabetes knowledge of low-income fifth grade students
Karen J Coleman, Andrea Yoder Clark, Maggie Shordon, et al.
Drug Discovery Today
|
February 15, 2023
Role of innovation in pharmaceutical regulation: A proposal for principles to evaluate EU General Pharmaceutical Legislation from the innovator perspective
Inkatuuli Heikkinen, Sini Eskola, Virginia Acha, et al.
Population Health Management
|
January 17, 2020
Care Team Integration in Primary Care Improves One-Year Clinical and Financial Outcomes in Diabetes: A Case for Value-Based Care
Addie L Fortmann, Chris Walker, Kelly Barger, et al.
International Journal of Cancer
|
March 7, 2020
Phase 1 study of epacadostat in combination with atezolizumab for patients with previously treated advanced nonsmall cell lung cancer
Matthew D Hellmann, Scott Gettinger, Laura Q M Chow, et al.
Targeted Oncology
|
February 14, 2023
First-in-Human Study of INCB062079, a Fibroblast Growth Factor Receptor 4 Inhibitor, in Patients with Advanced Solid Tumors
James J Harding, Christiane Jungels, Jean-Pascal Machiels, et al.
Applied Optics
|
August 22, 2008
The Hertz/VPM polarimeter: design and first light observations
Megan Krejny, David Chuss, Christian Drouet d'Aubigny, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
March 2, 2022
Cardiorenal risk of celecoxib compared with naproxen or ibuprofen in arthritis patients: insights from the PRECISION trial
Slayman Obeid, Peter Libby, Elaine Husni, et al.
The American Journal of Gastroenterology
|
March 15, 2018
Acute pancreatitis with long-term celecoxib vs. ibuprofen or naproxen: data from the PRECISION trial
Neville D Yeomans, David Y Graham, Qiuqing Wang, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 8, 2023
Phase 1/2 Study of the Pan-PIM Kinase Inhibitor INCB053914 Alone or in Combination With Standard-of-Care Agents in Patients With Advanced Hematologic Malignancies
Manish R Patel, William Donnellan, Michael Byrne, et al.
Cancer
|
October 30, 2022
Phase 1/2 study of epacadostat in combination with durvalumab in patients with metastatic solid tumors
Aung Naing, Alain P Algazi, Gerald S Falchook, et al.
Page
of 7